NCT02441517 2018-04-19A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel TreatmentAstellas Pharma IncPhase 4 Terminated4 enrolled 12 charts